We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$166M
AUM Growth
+$3.17M
Cap. Flow
-$1.3M
Cap. Flow %
-0.78%
Top 10 Hldgs %
44.41%
Holding
217
New
17
Increased
28
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.32M
2
KMI icon
Kinder Morgan
KMI
+$1.51M
3
AGN
Allergan plc
AGN
+$1.03M
4
CMCSA icon
Comcast
CMCSA
+$369K
5
VOD icon
Vodafone
VOD
+$168K

Top Sells

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.51M
2
TWX
Time Warner Inc
TWX
+$1.82M
3
BKNG icon
Booking.com
BKNG
+$1.78M
4
QCOM icon
Qualcomm
QCOM
+$1.55M
5
MSFT icon
Microsoft
MSFT
+$155K

Sector Composition

Rank Sector Weight
1 Technology 18.39%
2 Energy 18.15%
3 Financials 14.33%
4 Healthcare 12.43%
5 Communication Services 11.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWTR
176
DELISTED
Twitter, Inc.
TWTR
$7K ﹤0.01%
400
– –
MSP
177
DELISTED
Madison Strategic Sector
MSP
$7K ﹤0.01%
600
– –
APA icon
178
APA Corp
APA
$13.2B
$6K ﹤0.01%
100
– –
CLB icon
179
Core Laboratories
CLB
$488M
$6K ﹤0.01%
+50
New +$5.54K
VCV icon
180
Invesco California Value Municipal Income Trust
VCV
$518M
$6K ﹤0.01%
500
– –
XBI icon
181
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$6K ﹤0.01%
105
– –
CORT icon
182
Corcept Therapeutics
CORT
$12.4B
$5K ﹤0.01%
700
– –
B
183
Barrick Mining
B
$61.5B
$5K ﹤0.01%
300
– –
MGK icon
184
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
$5K ﹤0.01%
300
– –
NKE icon
185
Nike
NKE
$61.9B
$5K ﹤0.01%
100
– –
BKD icon
186
Brookdale Senior Living
BKD
$3.49B
$4K ﹤0.01%
300
+200
+200% +$2.69K
IONS icon
187
Ionis Pharmaceuticals
IONS
$8.6B
$4K ﹤0.01%
90
– –
LEN icon
188
Lennar Class A
LEN
$19.8B
$4K ﹤0.01%
109
– –
QQQX icon
189
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.44B
$4K ﹤0.01%
210
– –
CG icon
190
Carlyle Group
CG
$16.6B
$3K ﹤0.01%
200
-1,100
-85% -$17K
JPC icon
191
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$3K ﹤0.01%
300
– –
YUM icon
192
Yum! Brands
YUM
$41.8B
$3K ﹤0.01%
40
-16
-29% -$1K
MNDT
193
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3K ﹤0.01%
250
– –
GM.WS.B
194
CALL
DELISTED
General Motors Company
GM.WS.B
$3K ﹤0.01%
198
– –
STJ
195
DELISTED
St Jude Medical
STJ
$3K ﹤0.01%
40
– –
QGENF
196
DELISTED
QIAGEN NV
QGENF
$3K ﹤0.01%
124
– –
ETSY icon
197
Etsy
ETSY
$7.75B
$2K ﹤0.01%
150
– –
JRS icon
198
Nuveen Real Estate Income Fund
JRS
$249M
$2K ﹤0.01%
150
– –
ASIX icon
199
AdvanSix
ASIX
$541M
$1K ﹤0.01%
+43
New +$772
C icon
200
Citigroup
C
$222B
$1K ﹤0.01%
23
– –
5 6 7
8
9

Similar funds

HCP
Hexagon Capital Partners Rogers, Arkansas $683M AUM 34.85% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $685M AUM 15.32% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Blume Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Blume Capital Management held 217 positions worth $166M, up 1.9% from $163M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Blume Capital Management's Q4 2016 filing shows 17 new, 28 increased, 43 reduced and 7 closed positions. Its largest new stake was Teva Pharmaceuticals: 83,115 shares worth $3.01M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Energy and Financials.

  • Blume Capital Management's largest Q4 2016 buy was Teva Pharmaceuticals: 83,115 shares worth $3.01M.
  • Blume Capital Management added most to Kinder Morgan in Q4 2016, an estimated $1.51M increase.
  • Blume Capital Management's biggest Q4 2016 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $2.51M.
  • Blume Capital Management fully exited Gen Digital in Q4 2016, selling an estimated $64K.
  • Blume Capital Management's ten largest holdings make up 44% of its $166M portfolio in Q4 2016.
  • Blume Capital Management opened 17 new positions and closed 7 in Q4 2016.
  • Blume Capital Management's portfolio value rose 1.9% quarter-over-quarter to $166M.

Based on Blume Capital Management's 13F filing for Q4 2016, filed 30 Jan 2017.